side effects for glp-1 adverse of glp 1 The current significance and prospects the use dual receptor agonism GLP-1/Glucagon Many patients taking glucagon-like peptide-1 – If you're on a GLP-1

In subsequent papers, we will explore AI-enabled drug discovery in more depth as an emerging and increasingly investable theme examining the key catalysts and evidence base that could translate scientific progress into durable value creation

In vitro , exposure of human esophageal epithelial cells to LES significantly upregulated TLR2 expression and downregulated claudin-1 and DIS expression

Read the privacy and consent documents the way you'd read a contract - because that's what they are - and ask before you sign rather than after

Graphical Abstract Similar content being viewed by others Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter 2 inhibitors (SGLT2) are key treatments for type 2 diabetes that improve cardiovascular and renal outcomes [1,2,3]